Here are five things to know:
• Integra Lifesciences has received a consensus rating of “Buy” from the seven analysts that are covering the company.
• The company has a one-year low of $42.50 and a one-year high of $61.26.
• The stock’s 50-day moving average is $57.
• The stock’s 200-day moving average is $51.
• The company has a market cap of $1.97 billion.
More articles on devices:
NuVasive, Medtronic patent saga continues — 5 key updates
InVivo goes from illiquid to a top-traded stock: 5 key notes
6 key notes on Mazor Robotics’ short interest decline
